Lori Laffel M.D., M.P.H.
 

Lori Laffel, MD, MPH is Chief of the Pediatric, Adolescent and Young Adult Section and Head of the Section on Clinical, Behavioral and Outcomes Research at the Joslin Diabetes Center, as well as a Professor of Pediatrics at Harvard Medical School.

Dr. Laffel’s research aims to prevent the late complications of Type 1 and Type 2 diabetes and preserve the health, normal growth, development, and family functioning of children, adolescents, and young adults with diabetes. A major focus of Dr. Laffel’s research is the use of technologies, such as CGM, automated insulin delivery, and text messaging systems, in diabetes management. She is an expert in the area of CGM use in youth with Type 1 diabetes and was co-chair of the landmark multi-site JDRF CGM RCT. Dr. Laffel is also a Principal Investigator and member of the National Steering Committee for the NIH-funded TODAY study, the largest clinical trial involving youth with Type 2 diabetes to date. Dr. Laffel has published more than 200 peer-reviewed research articles.

Dr. Laffel has served on numerous advisory committees for the American Diabetes Association (ADA) and the JDRF. She is the co-editor of the ADA/JDRF Sourcebook on Type 1 Diabetes through the Life Span. She is also a current member of the JDRF's Research Advisory Committee. Dr. Laffel has received multiple awards, including the 2015 American Diabetes Association Outstanding Physician-Clinician Award, the 2016 Greater Boston Chamber of Commerce Pinnacle Award, and the 2016 University of Miami Miller School of Medicine Hall of Fame Award.

Dr. Laffel received her MD from the University of Miami School of Medicine and her MPH from the Harvard School of Public Health. She completed her post-doctoral training at Boston Children's Hospital and the Joslin Diabetes Center.


Laffel

​Office Phone Number: 1-617-309-4530

lori(dot)laffel(at)joslin(dot)harvard(dot)edu